Correlation Between Alphabet and Arch Biopartners
Can any of the company-specific risk be diversified away by investing in both Alphabet and Arch Biopartners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and Arch Biopartners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphabet Inc Class C and Arch Biopartners, you can compare the effects of market volatilities on Alphabet and Arch Biopartners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of Arch Biopartners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and Arch Biopartners.
Diversification Opportunities for Alphabet and Arch Biopartners
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Alphabet and Arch is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc Class C and Arch Biopartners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arch Biopartners and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc Class C are associated (or correlated) with Arch Biopartners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arch Biopartners has no effect on the direction of Alphabet i.e., Alphabet and Arch Biopartners go up and down completely randomly.
Pair Corralation between Alphabet and Arch Biopartners
Given the investment horizon of 90 days Alphabet Inc Class C is expected to under-perform the Arch Biopartners. But the stock apears to be less risky and, when comparing its historical volatility, Alphabet Inc Class C is 1.45 times less risky than Arch Biopartners. The stock trades about -0.02 of its potential returns per unit of risk. The Arch Biopartners is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 186.00 in Arch Biopartners on September 1, 2024 and sell it today you would earn a total of 9.00 from holding Arch Biopartners or generate 4.84% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 91.3% |
Values | Daily Returns |
Alphabet Inc Class C vs. Arch Biopartners
Performance |
Timeline |
Alphabet Class C |
Arch Biopartners |
Alphabet and Arch Biopartners Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Alphabet and Arch Biopartners
The main advantage of trading using opposite Alphabet and Arch Biopartners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, Arch Biopartners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arch Biopartners will offset losses from the drop in Arch Biopartners' long position.The idea behind Alphabet Inc Class C and Arch Biopartners pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Arch Biopartners vs. NervGen Pharma Corp | Arch Biopartners vs. Nanalysis Scientific Corp | Arch Biopartners vs. Perimeter Medical Imaging | Arch Biopartners vs. Medicenna Therapeutics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |